Public perceptions of predictive testing for rheumatoid arthritis compared to breast cancer and early-onset Alzheimer's disease: a qualitative study

被引:6
|
作者
Singhal, Juhi [1 ]
Wells, Imogen [2 ]
Simons, Gwenda [2 ]
Wohlke, Sabine [3 ]
Raza, Karim [2 ,3 ,4 ,5 ]
Falahee, Marie [2 ]
机构
[1] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England
[2] Univ Birmingham, Queen Elizabeth Hosp, Coll Med & Dent Sci,Res Labs, Inst Inflammat & Ageing,Rheumatol Res Grp, Birmingham B15 2WB, W Midlands, England
[3] Hamburg Univ Appl Sci, Fac Life Sci, Dept Hlth Sci, Hamburg, Germany
[4] MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Birmingham, W Midlands, England
[5] Univ Birmingham, Coll Med & Dent Sci, Res Inflammatory Arthrit Ctr Versus Arthrit, Birmingham B15 2TT, W Midlands, England
关键词
Predictive testing; Risk perception; Rheumatoid arthritis; Breast cancer; Early-onset Alzheimer's disease; Focus groups; ECONOMIC BURDEN; RISK; DIAGNOSIS; DELAY;
D O I
10.1186/s41927-021-00244-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is increasing research focus on prediction and prevention of rheumatoid arthritis (RA). Information about risk of RA is increasingly available via direct-to-consumer testing. However, there is limited understanding of public perceptions around predictive testing for RA. This study explores public perceptions of predictive testing for RA in comparison to breast cancer (BC) and early-onset Alzheimer's disease (AD). Methods Four focus groups with 21 members of the public were conducted using hypothetical vignettes about predictive testing for each disease. Transcripts of focus group proceedings were analysed inductively using thematic analysis. Results Thematic analysis of the data produced three key themes: decision-making factors, consequences, and consumer needs. Factors suggested that might influence decision-making about predictive testing included family history, fear, and perceived severity and treatability of the illness. RA was perceived to be less severe and more treatable than BC/AD. Potential consequences of predictive testing across all diseases included lifestyle modification, planning for the future and discrimination by employers or insurers. Predictive testing for RA was perceived to have less potential for negative psychological consequences than other diseases. Participants highlighted that individuals undertaking predictive testing should be signposted to appropriate support services and receive information on the accuracy of predictive testing. It was suggested that strategies to mitigate concerns regarding communication and confidentiality of risk results are required. Conclusions The findings of this study reflect public misunderstandings regarding RA that may impact the uptake of and responses to predictive testing, and key informational needs of individuals considering a predictive test. Predictive strategies should be accompanied by awareness-raising initiatives and informational resources.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Public perceptions of predictive testing for rheumatoid arthritis compared to breast cancer and early-onset Alzheimer’s disease: a qualitative study
    Juhi Singhal
    Imogen Wells
    Gwenda Simons
    Sabine Wöhlke
    Karim Raza
    Marie Falahee
    BMC Rheumatology, 6
  • [2] QUALITATIVE STUDY OF PUBLIC PERCEPTIONS OF PREDICTIVE GENETIC TESTING FOR RHEUMATOID ARTHRITIS
    Wells, Imogen
    Simons, Gwenda
    Woehlke, Sabine
    Schicktanz, Silke
    Hansson, Mats
    Raza, Karim
    Falahee, Marie
    RHEUMATOLOGY, 2019, 58 : 186 - 186
  • [3] Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
    Kumar, Kanta
    Peters, Sarah
    Barton, Anne
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17 : 1 - 6
  • [4] Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
    Kanta Kumar
    Sarah Peters
    Anne Barton
    BMC Musculoskeletal Disorders, 17
  • [5] PERCEPTIONS OF PATIENTS WITH RHEUMATOID ARTHRITIS ABOUT PREDICTIVE TESTING FOR TREATMENTS: A QUALITATIVE STUDY
    Kumar, K.
    Cordingley, L.
    Maskell, D.
    Nair, N.
    Barton, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1304 - 1304
  • [6] Predictive Factors for Disease Progression in Patients With Early-Onset Alzheimer's Disease
    Yoon, Bora
    Shim, Yong S.
    Park, Hee-Kyung
    Park, Sun Ah
    Choi, Seong Hye
    Yang, Dong Won
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (01) : 85 - 91
  • [7] Presenilins and early-onset Alzheimer's disease
    van Duijn, CM
    Cruts, M
    Backhovens, H
    Theuns, J
    Van Gassen, G
    Hofman, A
    Van Broeckhoven, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A214 - A214
  • [8] Perceptions of Knowledge, Disease Impact and Predictive Genetic Testing in Family Members at Risk to Develop Early-Onset Alzheimer's Disease (EOAD) and Their Levels of Suicidal Ideation: A Mixed Study
    Reyes-Dominguez, Yesica Arlae
    Figuera, Luis E.
    Brambila-Tapia, Aniel Jessica Leticia
    BRAIN SCIENCES, 2023, 13 (03)
  • [9] Early-onset Alzheimer disease - When is genetic testing appropriate?
    Goldman, JS
    Hou, CE
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 (02): : 65 - 67
  • [10] White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)
    Eloyan, Ani
    Thangarajah, Maryanne
    An, Na
    Borowski, Bret J.
    Reddy, Ashritha L.
    Aisen, Paul
    Dage, Jeffrey L.
    Foroud, Tatiana
    Ghetti, Bernardino
    Griffin, Percy
    Hammers, Dustin
    Iaccarino, Leonardo
    Jack, Clifford R., Jr.
    Kirby, Kala
    Kramer, Joel
    Koeppe, Robert
    Kukull, Walter A.
    La Joie, Renaud
    Mundada, Nidhi S.
    Murray, Melissa E.
    Nudelman, Kelly
    Rumbaugh, Malia
    Soleimani-Meigooni, David N.
    Toga, Arthur
    Touroutoglou, Alexandra
    Atri, Alireza
    Day, Gregory S.
    Duara, Ranjan
    Graff-Radford, Neill R.
    Honig, Lawrence S.
    Jones, David T.
    Masdeu, Joseph
    Mendez, Mario F.
    Musiek, Erik
    Onyike, Chiadi U.
    Rogalski, Emily
    Salloway, Stephen
    Sha, Sharon
    Turner, Raymond S.
    Wingo, Thomas S.
    Wolk, David A.
    Womack, Kyle
    Beckett, Laurel
    Gao, Sujuan
    Carrillo, Maria C.
    Rabinovici, Gil
    Apostolova, Liana G.
    Dickerson, Brad
    Vemuri, Prashanthi
    ALZHEIMERS & DEMENTIA, 2023, 19 : S89 - S97